MERCOSUR - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMERCOSUR: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in MERCOSUR
In 2021, the MERCOSUR medicaments containing insulin market was finally on the rise to reach $X for the first time since 2018, thus ending a two-year declining trend. In general, consumption continues to indicate a significant expansion. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.
Medicaments Containing Insulin Production in MERCOSUR
In value terms, medicaments containing insulin production dropped to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +3.1% over the period from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2020 with an increase of 19%. As a result, production attained the peak level of $X, and then shrank in the following year.
Medicaments Containing Insulin Exports
Exports in MERCOSUR
In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -81.8% to X kg, falling for the fifth year in a row after two years of growth. Over the period under review, exports saw a dramatic shrinkage. The most prominent rate of growth was recorded in 2016 when exports increased by 283%. As a result, the exports attained the peak of X kg. From 2017 to 2021, the growth of the exports remained at a somewhat lower figure.
In value terms, medicaments containing insulin exports shrank notably to $X in 2021. In general, exports continue to indicate a dramatic slump. The most prominent rate of growth was recorded in 2015 when exports increased by 482%. Over the period under review, the exports attained the peak figure at $X in 2016; however, from 2017 to 2021, the exports stood at a somewhat lower figure.
Exports by Country
In 2021, Colombia (X kg) was the major exporter of medicaments containing insulin but not antibiotics in MERCOSUR, mixing up 100% of total export.
Colombia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of -42.4% from 2012 to 2021. Colombia (+5.3 p.p.) significantly strengthened its position in terms of the total exports, while the shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Colombia ($X) also remains the largest medicaments containing insulin supplier in MERCOSUR.
From 2012 to 2021, the average annual growth rate of value in Colombia amounted to -38.9%.
Export Prices by Country
The export price in MERCOSUR stood at $X per ton in 2021, surging by 129% against the previous year. In general, the export price enjoyed a buoyant increase. The pace of growth appeared the most rapid in 2015 when the export price increased by 252%. As a result, the export price reached the peak level of $X per ton. From 2016 to 2021, the export prices remained at a somewhat lower figure.
As there is only one major export destination, the average price level is determined by prices for Colombia.
From 2012 to 2021, the rate of growth in terms of prices for Colombia amounted to +6.0% per year.
Medicaments Containing Insulin Imports
Imports in MERCOSUR
Medicaments containing insulin imports surged to X tons in 2021, rising by 410% compared with 2020. In general, imports continue to indicate a significant increase. As a result, imports attained the peak and are likely to continue growth in the immediate term.
In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. Over the period under review, imports recorded a significant increase. As a result, imports attained the peak and are likely to continue growth in the immediate term.
Imports by Country
The countries with the highest levels of medicaments containing insulin imports in 2021 were Brazil (X tons), together finishing at 99% of total import.
Brazil was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +42.6% from 2012 to 2021. While the share of Brazil (+44 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Brazil ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in MERCOSUR.
From 2012 to 2021, the average annual growth rate of value in Brazil totaled +37.4%.
Import Prices by Country
In 2021, the import price in MERCOSUR amounted to $X per ton, picking up by 109% against the previous year. In general, the import price, however, showed a pronounced decline. Over the period under review, import prices attained the maximum at $X per ton in 2015; however, from 2016 to 2021, import prices remained at a lower figure.
As there is only one major supplying country, the average price level is determined by prices for Brazil.
From 2012 to 2021, the rate of growth in terms of prices for Brazil amounted to -3.7% per year.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing insulin market in MERCOSUR. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in MERCOSUR, split by region and country
- Trade (exports and imports) in MERCOSUR
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Argentina
- Brazil
- Chile
- Colombia
- Ecuador
- Guyana
- Paraguay
- Peru
- Suriname
- Uruguay
- Venezuela
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
- Medicaments Containing Insulin Market
- Polymer Ion-exchangers Market
- Phenolphthalein and Lactones Market
- Hydantoin Market
- Malonylurea and Its Derivatives Market
- Compounds Containing A Pyrimidine Ring Market
- Compounds Containing An Unfused Triazine Ring Market
- Compounds Containing A Phenothiazine Ring-system Market
- Sulphonamides Market
- Glycosides and Vegetable Alkaloids Market